As of 2025-12-31, the Relative Valuation of Guardant Health Inc (GH) is (79.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 100.60 USD, the upside of Guardant Health Inc based on Relative Valuation is -178.9%.
The range of the Relative Valuation is (70.57) - (87.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.8x - 34.2x | 28.3x |
| Forward P/E multiples | 18.2x - 28.1x | 23.0x |
| Fair Price | (70.57) - (87.04) | (79.39) |
| Upside | -170.2% - -186.5% | -178.9% |
| Date | P/E |
| 2025-12-30 | -32.50 |
| 2025-12-29 | -32.76 |
| 2025-12-26 | -33.27 |
| 2025-12-24 | -33.08 |
| 2025-12-23 | -33.12 |
| 2025-12-22 | -32.74 |
| 2025-12-19 | -32.22 |
| 2025-12-18 | -31.37 |
| 2025-12-17 | -31.49 |
| 2025-12-16 | -32.31 |
| 2025-12-15 | -33.17 |
| 2025-12-12 | -32.98 |
| 2025-12-11 | -32.75 |
| 2025-12-10 | -33.15 |
| 2025-12-09 | -33.34 |
| 2025-12-08 | -33.66 |
| 2025-12-05 | -32.96 |
| 2025-12-04 | -35.06 |
| 2025-12-03 | -34.23 |
| 2025-12-02 | -33.56 |
| 2025-12-01 | -33.99 |
| 2025-11-28 | -35.03 |
| 2025-11-26 | -34.82 |
| 2025-11-25 | -35.15 |
| 2025-11-24 | -35.94 |
| 2025-11-21 | -34.06 |
| 2025-11-20 | -32.40 |
| 2025-11-19 | -32.16 |
| 2025-11-18 | -30.88 |
| 2025-11-17 | -31.17 |
| 2025-11-14 | -30.49 |
| 2025-11-13 | -30.41 |
| 2025-11-12 | -31.61 |
| 2025-11-11 | -31.57 |
| 2025-11-10 | -31.64 |
| 2025-11-07 | -31.25 |
| 2025-11-06 | -31.10 |
| 2025-11-05 | -30.71 |
| 2025-11-04 | -31.71 |
| 2025-11-03 | -31.96 |
| 2025-10-31 | -30.05 |
| 2025-10-30 | -29.86 |
| 2025-10-29 | -23.35 |
| 2025-10-28 | -22.48 |
| 2025-10-27 | -22.89 |
| 2025-10-24 | -23.31 |
| 2025-10-23 | -22.41 |
| 2025-10-22 | -21.98 |
| 2025-10-21 | -21.81 |
| 2025-10-20 | -22.68 |